A systematic review and meta-analysis in the effectiveness of mobile phone interventions used to improve adherence to antiretroviral therapy in HIV infection
BMC Public Health volume 19, Article number: 915 (2019)
Antiretroviral therapy is effective in preventing the progression of HIV to AIDS, but adherence to HIV medication is lower than ideal. A previous Cochrane review concluded that SMS interventions increased adherence to HIV medication, but more recent trials have reported mixed results. Our review aims to provide an up-to-date synthesis of the effects of interventions delivered by mobile phone on adherence.
We searched Cochrane, Medline, CINAHL, EMBASE and Global Health for randomised control trials (RCTs) of interventions delivered by mobile phones, designed to increase adherence to antiretroviral medication. Risk of bias was assessed using the Cochrane risk of bias tool. We calculated relative risk ratios (RR) or standardised mean difference (SMD) with 95% confidence interval (CI). Trials were analysed depending on delivery mechanism and intervention characteristics. We conducted meta-analysis for primary objective outcome measures.
We identified 19 trials. No trials were at low risk of bias. Interventions were delivered as follows; nine via text message, five via mobile phone call, one via mobile phone imagery and four via mixed interventions. There was no effect when interventions delivered by text message were pooled in the RR1.25 (CI 0.97 to 1.61) P = 0.08. The SMD 0.42 (0.03 to 0.81) p = 0.04 showed a moderate effect to improve adherence. There was mixed evidence of the effect of text messages delivered daily, weekly, at scheduled or triggered times, however, messages with link to support, interactivity and three or more behavior change techniques (BCTs) all improved adherence. Of the five trials delivered by mobile phone call, one reported a reduction in HIV viral load. One trial using mobile phone imagery reported a reduction in HIV viral load. Three trials that delivered interventions by text message and mobile phone counselling reported improved biological outcomes.
Specific interventions, of proven effectiveness should be considered for implementation, rather than mobile phone-based interventions in general. Interventions targeting a wider range of barriers to adherence may be more effective than existing interventions. The effects and cost-effectiveness of such interventions should be evaluated in a randomised controlled trial alongside long term objective and clinically important outcomes.
There are currently over 36 million people worldwide living with HIV  with the majority from middle and low-income countries. Almost 70% of the global HIV disease burden is in Sub-Saharan Africa . Treatment with antiretroviral therapy (ART) enables people living with HIV (PLWH) to lead healthier and longer lives since the life expectancy of someone who responds to treatment is the same as the general population . Currently, 59% of PLWH have access to ART .
High adherence to ART is required to suppress viral replication, to slow the progression of HIV, and further reduce transmission . Poor adherence can also lead to drug resistance . UNAIDS aims to ensure 73% of PLWH achieve viral suppression which is thought to be 2 to 3 times higher than current levels of viral suppression  and the World Health Organisation (WHO) estimates that only one-third of the population adhere appropriately .
Factors influencing adherence include individual factors such as lack of knowledge, misunderstandings about administering medicines, lack of skills in developing regular medicine taking habits (remembering), concerns about side effects, and social support for medicine taking [8,9,10]. Medicine related factors, which affect adherence, include pill burden (number of tablets, intense dosing schedule, meal time restrictions, medicine side effects) [11,12,13]. Service and structural factors also play a role, such as the availability of medicine and cost of training health care providers [14, 15].
Interventions that have demonstrated efficacy in increasing adherence to HIV treatment have had multiple components including providing education, counselling, social support, feedback and additional supervision [11,12,13]. However, in most settings these have proven too costly or are unfeasible to deliver in routine service settings.
Mobile phones are a potentially useful, low cost, platform for delivering health interventions . The World Bank estimates that 93 in every 100 people are subscribed to mobile phones  with low-income countries being the fastest growing sector . Interventions delivered by mobile phones have the potential to target many of the factors influencing adherence such as knowledge, attitudes, concerns about medicines and difficulties in developing regular medicine taking habits [8,9,10]. They could enhance links to services so participants can obtain support and advice when needed, such as if they are experiencing medicine side effects . Where mobile phones are owned and used by individuals, privacy can be maintained which is vital for stigmatised diseases like HIV. Mobile phones are carried with people wherever they go, so advice and support can be provided in real time in the patient’s environment . Mobile phones also have the potential to provide support and training to health care providers, allow remote monitoring of medicine taking and monitoring of drug supplies with the potential to reduce drug stock.
A 2011 Cochrane systematic review of trials conducted between 1980 and 2011, included two trials of interventions delivered by mobile phone and concluded weekly messaging is effective in increasing adherence to ART . Other systematic reviews that have looked at text message also support these findings; Finnitis et al. , Mayer et al.  and Thakker et al.  suggest text messaging improves adherence. Wald et al.  looked at the difference between one-way and two-way message and found the latter improved adherence.
Our review aims to provide an updated synthesis of RCTs of interventions designed to increase adherence to ART medication delivered to patients via mobile phone. We aim to describe the effectiveness of interventions which employ different delivery mechanism (SMS, voice calls, application software) and different intervention content or frequencies of contact (weekly, daily contact). We will explore if the effects of interventions vary according to if they employ interactivity, links to support or use three or more BCTs.
This review was conducted in accordance with the PRISMA guidance. The flowchart can be found in Additional file 1.
Participants – Men and women of any age infected with HIV who are on or due to start ART. There was no restriction of age or stage of treatment.
Intervention – All controlled trials employing any mobile technology to deliver interventions to improve adherence to antiretroviral medication.
Study design – Randomised control trials.
Outcomes – Primary outcomes were objective measures, which include Medication Event Monitoring System (MEMS), pill count and biological outcomes (CD4 count and viral load). Secondary outcomes were subjective measures (self-reported adherence).
A review protocol does not exist. There were no language, geographical or publication status restrictions. We excluded trials that included more than one disease and all non-randomised trials including observational and cross-sectional study designs.
We searched; Cochrane, CINAHL, MEDLINE, EMBASE, and Global Health databases from 1990 to October 2017. The EMBASE search strategy of medical subject headings and text-words can be found in Additional file 2. These terms were combined with the Cochrane pre-set search terms for controlled trials. RS searched the reference lists of included papers to identify additional studies for this review. Two reviewers independently scanned the electronic records to identify potentially eligible trials.
Two reviewers independently extracted data on the intervention delivery mechanism (e.g. text message, phone call), intervention characteristics, trial quality and on measures of effect. Sensitivity analysis was run looking at intervention characteristics, defined as:
Link to support - an intervention that was linked to a health professional was considered as support, e.g. the provision of a telephone number.
Interactivity - when an intervention required the participant to respond once the intervention has been received for e.g. sending a text message back that “everything is okay”. Also referred to as two-way text message.
Behaviour change technique - authors description of interventions according to Abraham and Michie’s taxonomy of BCTs , Additional file 3. An arbitrary measure of three or more techniques were used as a cut-off as we estimate that this number is indicative of interventions which have considered behaviour change and a wider range of factors influencing adherence.
All discrepancies were agreed by discussion with a third reviewer.
Risk of bias was assessed according to the criteria outlined by the International Cochrane Collaboration . A cut off of 90% complete follow-up was used to determine low risk of bias for attrition.
Data analysis and synthesis
All analyses, including meta-analysis were conducted in Cochrane Review Manager . All outcomes have been analysed as intention-to-treat. All loss to follow up has been treated as non-adherent. We calculated risk ratios (RR) and standard mean differences (SMD). We used random effects meta-analysis appropriately to give pooled estimates of primary outcomes where there were two or more trials using the same mobile phone delivery mechanism (e.g. SMS messages) and the same measures of adherence. We examined heterogeneity visually by examining the forest plots and statistically using both the χ2 test and the I2 statistic. We assessed evidence of publication bias using Funnel plots.
The combined search strategies identified 511 electronic records. These were screened for eligibility and the full text of 46 potentially eligible reports were obtained for further assessment. Nineteen reports met the review inclusion criteria and represented 19 trials, the PRISMA flow diagram can be seen in Additional file 1. Trials that were excluded from this review can be found in Additional file 7. Three trials were excluded in meta-analysis; Nsagha  and Kebaya  only reported subjective outcomes and Hardy  had an intervention as part of the control group.
In total, the 19 trials included 2650 participants. Sample sizes ranged from 21 to 538 people, the median was 119 participants. Studies took place in South America (Brazil = 1), North America (USA = 4), Asia (India = 1, Pakistan =1, Malaysia =1, China = 2), Africa (Nigeria =1, Cameroon = 2, Uganda =1, South Africa = 1, Kenya = 3) and Australasia (New Zealand =1). All were presented in English. Most trials recruited men and women, however, two groups included only women [29, 31].
Interventions – delivery mechanism
Nine interventions were delivered via text message [28, 30,31,32,33,34,35,36,37], five interventions were delivered via mobile phone call [29, 38,39,40,41], one via mobile phone imagery , and four mixed interventions (one automated voice call with pictorial text ), two with counselling and text message [44, 45] and one with SMS and telephone call reminder . In all but one trial the control was usual care . The interventions lasted between 6 weeks and 96 weeks.
The maximum number of BCTs employed was 6  and the median number was 2. The most commonly used BCTs were: social support (13 interventions), association, for example prompts/cues (11 interventions) and feedback & monitoring (8 interventions). More than three BCTs were used in 5 of the trials [34, 35, 38, 40, 41]. Four trials specifically reported being based on behaviour change theory [33, 35, 41, 43] and these include social cognitive theory of planned behaviour [43, 47], health belief model , individual change model , and behavioural self-management .
Details of the interventions, as described by the authors are described in Table 1.
Fifteen different adherence outcome measures were reported. Primary objective outcome measures reported include six trials recordings MEMs, seven viral measures (5 reported viral load and 2 viral failure) and three trials measured pill count and CD4 count. The most frequently reported measure of adherence was the subjective secondary outcome, self-reported adherence, in 14 trials. A complete list is found in Additional file 4.
A risk of bias summary for each trial is presented in Table 2 with comments in Additional file 5 . No trials had a low risk of bias for all criteria assessed. A funnel plot to show publication bias can be found in Additional file 6.
Interventions delivered by text message
Nine trials evaluated interventions delivered by text message [28, 30,31,32,33,34,35,36,37] which reported a total of 26 outcomes. An improvement in adherence was measured in seven of the 19 objective primary outcomes and two of the seven subjective secondary outcomes. The pooled measures of text message interventions to improve adherence measured as MEMs was RR 1.25 (CI 0.97 to 1.61) P = 0.08, observed heterogeneity I2 is 74% [31, 32, 34, 37] and SMD 0.42 (CI 0.03 TO 0.81) P = 0.04, I2 28% [35, 36].
There was substantial variation in all the text message interventions. The frequency of text messaging was observed in Pop-eleches trial  which compared weekly and daily messages with the length of the message (long /short). Of these arms, only weekly text messages showed a significant result, which was not consistent in the Mbugbaw trial  where weekly text messages were also delivered. Three trials looked at daily text messages [30, 32, 35] of which two improved adherences [30, 35]. Some text message interventions were coordinated to their ART regime (scheduled) [30, 31] and others used real time monitoring which only sent a text reminder if the participant failed to open the medication device (triggered) [34, 36, 37]. Haberer  specifically looked at this function and split participants into scheduled and triggered. In this trial scheduled showed an effect, which was also supported by Hardy . Triggered interventions showed an effect in two trials [34, 37]. Some trials only included participants with poor baseline adherence [30, 34, 35] and all of these trials reported that the intervention improved adherence. For biological measures, neither Orrell  or Haberer  reported a statistically significant HIV RNA suppression, however the Orrell trial  did report a statistically significant odds ratio for virological failure which has been asterisked in Table 3.
Interactivity was identified in 2 trials [30, 35] and both reported statistically significant improvements in adherence. Three or more BCTs were identified in 3 trials [34,35,36], all of which reported an improvement in adherence. Mbuagbaw  and Ingersoll  stated a behaviour change model that underpinned the intervention. Link to support was reported in one trial  which had a statistically significant effect when the adherence threshold was reduced from 95 to 90% for Visual Analogue Scale (VAS).
Interventions delivered by mobile phone call
Five trials evaluated interventions delivered by mobile phone call which reported a total of 12 outcomes [29, 38,39,40,41]. An improvement in adherence was measured in one of the 6 objective primary outcomes and in three of the 6 secondary subjective outcomes reported. One trial  showed a reduction in HIV viral load. The Huang  trial split the group into treatment naïve and treatment experienced. Two trials looked at participants that were not adherent [38, 41], only Belzer  improved adherence. No trials were similar enough to pool (Table 4).
Link to support was identified in 3 trials [38, 39, 41] and three or more BCTs were found in 3 trials [38, 40, 41]. Of these only Belzer  showed an improvement in adherence. Only Kalichman  explicitly stated a behaviour change model that underpinned the intervention. Mobile phone calls by nature were interactive.
Interventions delivered by mobile phone imagery
Interventions delivered by mixed intervention
Four trials evaluated interventions delivered by mixed mechanism [43,44,45,46] and reported a total of 10 outcomes. There were six primary outcomes and four secondary outcomes. All of the outcomes except for the Shet trial  reported improvements in adherence. The Adbulrahman trial  reported a difference in mean adherence in the intervention group as statistically significant (p = 0.035). They also reported significant biological differences between the control and intervention group - a significantly higher rise in CD4 count (p = 0.017) in the intervention group and higher viral load in the control group (p = 0.001). In both Abdulrahman  and Maduka’s trial  we were unable to calculate RR or MD based on the data provided. Maduka’s report a statistically significant (95% CI P = 0.007) improvement in median CD4 count . The Lester trial  which also involved text messaging and telephone follow up (for those requesting it or not responding) showed a statistically significant improvement in adherence (Table 6).
Interactivity was identified in three trials [43,44,45] of which two showed an effect. Link to support was identified in two trials [44, 45] all showed statistically significant improvements in adherence. Maduka  reported improvements in adherence in both objective and subjective measures (CD4 improvement and SRA). None of the mixed interventions used behaviour change models or reported having more than three or more BCTs as part of their interventions.
We identified 19 trials that investigated the effect of different mobile phone mechanisms on adherence to HIV medication. This review used a systematic approach, a replicable search strategy and standard systematic review methods  and is the first to include interventions delivered by mobile phone call. Previous reviews of mobile phone interventions designed to increase ART adherence have grouped all “mobile phone interventions that used any text messages” together without differentiating between interventions delivered via text message and mobile phone call, and BCTs used in the interventions were not described.
We present pooled analyses of objective outcomes and our review is the first to differentiate between objective and subjective adherence measures. Self-reported adherence outcomes may differentially overestimate benefits in the intervention group  due to lack of participant blinding, recall bias and the desire to please the provider . We only pooled objective measures of the same outcome as such analyses allow the clinical benefits achieved for patients to be more clearly interpreted.
We found no effect when interventions delivered by text message were pooled in the RR, however, there was a moderate effect in SMD. There was substantial heterogeneity across the trials and individual trials reported objective improvements in adherence. It was unclear if the delivery mechanism (daily, weekly, scheduled or triggered mechanism in text messages) had an effect since, individually, the results were of mixed statistical significance. Text message interventions described as ‘interactive’ and using more than three BCTs all showed improvements in adherence. None of the trials had a low risk of bias.
Previous reviews have found that text messaging is effective in increasing adherence to ART [19, 22, 23], Finitsis et al. , reported a pooled OR of 1.48 (1.09 to 2.01) on any HIV outcome, however, objective and subjective outcomes were pooled across all types of intervention provided they included some text messaging. Although pooling in this way affords greater statistical power, use of subjective outcomes in trials where participants cannot be blinded may have resulted in over-estimated effects and it is difficult to identify which intervention components were effective. A similar methodology was used in Thakkar et al.  which concluded that mobile phone text message approximately doubles medication adherence in chronic disease. This review included trials [44, 45] combining text message with counselling, which may have inflated results . Mayer et al.  also reported a larger SMD than the SMD we calculate in our review (SMD 0.87 vs. SMD 0.42), however, the authors included trials with a pre-post study design, converted all outcomes to SMD, and pooled all trials that included any text message.
We find the effect of text message-delivered daily prompts to take medicines to be inconclusive. This is consistent with the findings of other trials of text message-delivered daily prompts designed to increase adherence to oral contraception, TB medication, malaria prophylaxis or antibiotics, pooled RR 1.0 (CI 0.77–1.3) [31, 33, 50]. Intervention fatigue may explain the ineffectiveness of daily medication prompts.
All text message interventions with interactivity included in this review improved adherence, however we were unable to pool results (differing outcome measures and Hardy et al.  used an intervention as the control). This finding supports the conclusions of the Wald et al.  systematic review which explored the effects of two-way communication and interactivity in mobile phone-delivered interventions targeting adherence to any medication and concluded that interventions involving two-way text messaging improved medication adherence . Mbuagbaw et al. also showed that interactivity improved adherence to ART  and Finnitis reports that interventions which include interactivity are more effective .
In our review, we distinguish between interactivity and a specific link to support from a person. These characteristics were heterogeneous, which is unsurprising given the nature of interactivity varied e.g. texting back to confirm you have taken medicine rather than texting back if you would like to speak to a health care provider, and the nature of the link to support could require passive or active involvement (a phone call from a health care provider because you requested one or because you didn’t respond or a telephone number to call if further advice was needed). Trials of interventions that involve sending a text message and providing phone follow up from a health care provider report increased uptake of long acting contraception and increase adherence to preventative medication for cardiovascular disease, as well as increase adherence to antiretroviral medication and reduce viral load [52, 53].
Among the five trials of interventions delivered by mobile phone call included in this review, only one reported a statistically significant reduction in viral load post intervention . One trial using mobile phone imagery reported a reduction in HIV viral load. It is likely that the effect of interventions delivered by mobile phone call would be similar to the effect of adherence interventions delivered by landline - SMD in pooled behavioural outcomes 0.49 (− 1.12 to 2.11) I240%, . The content of calls in both our review and the Cochrane review of phone calls was generally poorly described and is likely to be variable, resulting in different effects across trials . In the one trial in our review which reported beneficial effects, the intervention was well described and involved confirming if medications were taken, providing problem-solving support, and referral to services to address adherence barriers if needed .
Of the mixed trials in our review, one trial delivered by mobile automated phone voice messaging showed no benefit, however, the other three mixed trials reported benefit, either in increasing CD4 count or reducing viral load [44,45,46]. All of the mixed interventions which included a link to support improved adherence, however, the time and costs involved requires clarification.
A wide range of other factors influence adherence to ART but have not been targeted in interventions to date. These factors include information about how medicines work, why they are important and how to take them, how to develop regular medicine taking habits, reassurance regarding common minor side effects and information about side effects for which help should be sought. The interventions in this review contained few BCTs (median 2 and maximum 6). In other areas such as smoking cessation effective behaviour change interventions delivered by text message included 19 BCTs .
Our review has some important limitations. With no existing gold standard objective measures of adherence [56, 57], trials included in this review used 15 different adherence measures limiting our ability to conduct pooled analyses of the same outcomes. There were also too few trials to conduct a meta-regression exploring all the factors which could influence heterogeneity of outcomes including: allocation concealment, blinding of outcome assessors, types of participant (treatment experienced/naive), factors influencing adherence targeted, BCT employed, mode of delivery, and duration of follow up.
Adherence measures may be at risk of the ‘Hawthorne effect’, where participants alter their behaviour due to awareness of being observed, especially if there is considerable contact in mid-trial follow-up points . Self-reported measures and measures that can be manipulated in the short term such as pill count will be more susceptible to this effect.
It is also important to consider that in RCT’s the control group may have higher adherence levels by virtue of trial participation and increased surveillance, which may reduce the ability to detect true differences in the trial and thus underestimate intervention effects. In pragmatic trials there may be a trade-off between maintaining internal validity by achieving high follow up and achieving generalisability for “real world” purposes.
We coded the BCTs using an established taxonomy , however, coding was dependant on the authors’ description of the intervention, which often lacked detail. More comprehensive descriptions were requested but responses were limited, especially for transcripts of mobile phone call interventions. It is likely that content of mobile phone calls differed between trials which may influence the outcome of mobile phone counselling interventions.
Many of the trials had small sample sizes and were therefore underpowered to detect changes in the outcomes collected. As mentioned before, we did not pool analyses across different outcomes also resulting in reduced statistical power. The median follow-up time across trials was 4 months which is insufficient to determine the long-term impact of the intervention - some studies suggest that adherence slowly decreases with time due to pill fatigue .
WHOs current advice is there is high quality evidence for weekly text messages and they are effective to enhance adherence  . The evidence is more nuanced than this advice suggests, and new recommendations based on the updated evidence can now be made which recommend only specific interventions that have been shown to be effective.
Cost-analyses of existing effective interventions is needed prior to considering widespread implementation. Further clarification regarding the aims or content of phone calls would be helpful for services considering implementation. Future trials should include an exploration of the mechanism of action of interventions. The evidence base would be enhanced if a gold standard measure of ART adherence were agreed internationally. Interventions targeting a wider range of factors influencing adherence might have greater effects than existing interventions and should be evaluated by randomised controlled trial.
Our review demonstrates text message improves adherence when measured as SMD but not RR. Interventions delivered by text message combined with health care provider mobile phone call have benefits on clinically important outcomes and text message interventions that include a link to a health care professional, interactivity and three or more BCTs all showed improvements in objective adherence measures. The evidence supports consideration of specific interventions shown to be effective for implementation, rather than mobile phone-based interventions in general. Interventions targeting a wider range of barriers to adherence and exploring other mechanisms may be more effective than existing interventions and may reduce the amount of health care provider input needed. Such interventions should be evaluated in a randomised controlled trial with long-term objective and clinically important outcomes alongside associated cost-effective analysis.
Behavioural change theory
Medication event monitoring
People living with HIV
Randomised control trial
Standardised mean difference
Visual analogue scale
World Health Organisation
WHO. Data and statistics HIV/AIDS 2019 [cited 2019 3/3]. Available from: https://www.who.int/hiv/data/en/.
World Health Organization. Global Health Observatory (GHO) data 2017 [cited 31/01/2017]. Available from: http://www.who.int/gho/hiv/en/.
NHS. What is the life expectancy for someone with HIV? 2015 [cited 31/01/2017]. Available from: http://www.nhs.uk/chq/Pages/3106.aspx?CategoryID=118&SubCategoryID=126.
Schneider JKS, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med. 2004;19(11):1096–103.
AIDS Info. HIV Treatment Adherence 2019 [cited 2019 5/5]. Available from: https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/21/54/hiv-treatment-adherence.
UNAIDS. 90–90–90 an ambitious treatment target to help end the AIDS epidemic, 2014.
WHO. Adherence to long term therapies. Evidence for action 2003.
Belzer MEFD, Luftman GS, Tucker DJ. Antiretroviral adherence issues among HIV-positive adolescents and young adults. J Adolesc Health. 1999;25(5):316–9.
Naar-King S TT, Wright K, Frey M, Parsons JT, Lam P. Psychosocial factors and medication adherence in HIV-positive youth. AIDS Patient Care STDs. 2006;20(1):44–7.
Rao DKT, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19(1):28–33.
Haynes RMK, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348(9024):383–6.
Amico KHJ, Johnson B. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285–97.
Simoni JPC, Pantalone D, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;(43(Suppl 1):S23–35.
Heckman TGSA, Kalichman SC, et al. Psychosocial differences between urban and rural people living with HIV/AIDS. J Rural Health. 1998;14:138–45.
Tufts KA, Johnson KF, Shepherd JG, Lee JY, Bait Ajzoon MS, Mahan LB, et al. Novel interventions for HIV self-management in African American women: a systematic review of mHealth interventions. J Association Nurses AIDS Care : JANAC. 2015;26(2):139–50.
Free C, Knight R, Robertson S, Whittaker R, Edwards P, Zhou W, Rodgers A, Cairns J, Kenward MG, Roberts I. Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet. 2011;378(9785):49–55.
Bank TW. World development indicators: power and communications 2015. World development indicators. Available from: http://wdi.worldbank.org/table/5.11.
Sciadas G GrP, Adarn L. From the digital divide to digital opportunities: measuring infostates for development: Orbicom International Secretariat; 2005.
Horvath T, Azman H, Kennedy GE, Rutherford GW. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. The Cochrane database of systematic reviews. 2012;3:Cd009756.
Heron KESJ. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol. 2010;15(Pt 1):1–39.
Finitsis DJ, JAP BTJ. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS One. 2014;9(2):e88166. https://doi.org/10.1371/journal.pone.0088166.
Mayer Jonathan PF. Meta-analysis on the effect of text message reminders for HIV-related compliance. AIDS Care. 29(4):409–17 DOI: 101080/0954012120161214674. 2017.
Thakkar J, Kurup R, Laba T-L, Santo K, Thiagalingam A, Rodgers A, Woodward M, Redfern J, Chow CK. Mobile telephone text messaging for medication adherence in chronic disease a meta-analysis. JAMA Intern Med. 2016;176(3):340–9. https://doi.org/101001/jamainternmed20157667.
David S, Wald M. FRCP, Shahena butt, MSc, Jonathan P. Bestwick, MSc. One-way versus two-way text messaging on improving medication adherence: meta-analysis of randomized trials. Am J Med. 2015;10:128.
Abraham C, Michie S. A taxonomy of behavior change techniques used in interventions. Health wPsychology. 2008;27(3):379–87.
Collaboration TC. The Cochrane Highly Sensitive Search Strategies for identifying randomized trials in MEDLINE 2011. Available from: http://handbook.cochrane.org/chapter_6/6_4_11_1_the_cochrane_highly_sensitive_search_strategies_for.htm.
Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre TCC, 2014.
Nsagha Dickson IL, Fon PN, Assob JCN, Tanue EA. A randomized controlled trial on the usefulness of Mobile text phone messages to improve the quality of care of HIV and AIDS patients in Cameroon. The Open AIDS Journal. 2016;2016(10):93–103.
L Kebaya RN, Wamalwa D, Kariuki N, Bashir A. Efficacy of Mobile phone use on adherence to Nevirapine prophylaxis and retention in care among the Hiv-exposed infants in Pmtct: a randomised controlled trial. Arch Dis Child. 2014(99:Suppl 2 A329. https://doi.org/10.1136/archdischild-2014-307384.911.
Hardy H, Kumar V, Doros G, Farmer E, Drainoni ML, Rybin D, et al. Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDs. 2011;25(3):153–61.
da Costa TM, Barbosa BJ, Gomes e Costa DA, Sigulem D, de Fatima Marin H, Filho AC, et al. Results of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDS-infected Brazilian women and impressions and satisfaction with respect to incoming messages. Int J Med Inform. 2012;81(4):257–69.
Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. Aids. 2011;25(6):825–34.
Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills EJ, Smieja M, et al. The Cameroon Mobile phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One. 2012;7(12):e46909.
Sabin Lora MBD, Gill CJ, Li Z, Vian T, Wubin X, Feng C, Keyi X, Guanghua L, Haberer JE, Bangsberg DR, Yongzhen L, Lu H, Gifford AL. Improving adherence to antiretroviral therapy with triggered real time text message reminders: the China through technology study (CATS). J Acquir Immune Defic Syndr. 2015;69(5):551–9.
RA Dillingham IKS, Hettema JE, Conaway M, Freeman J, Reynolds G, Hosseinbor S. Pilot RCT of bidirectional text messaging for ART adherence among nonurban substance users with HIV. Health Psychol. 2015;34(0):1305–15.
Haberer Jessica EAM, Atukunda EC, Musinguzi N, Wyatt MA, Ware NC, Bangsberg DR. Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016;30:1295–9.
Orrell Catherine KC, Mauff K, Bangsberg DR, Maartens G, Wood R. A randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;70:495–502.
Belzer ME, Naar-King S, Olson J, Sarr M, Thornton S, Kahana SY, et al. The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial. AIDS Behav. 2014;18(4):686–96.
Huang D, Sangthong R, McNeil E, Chongsuvivatwong V, Zheng W, Yang X. Effects of a phone call intervention to promote adherence to antiretroviral therapy and quality of life of HIV/AIDS patients in Baoshan, China: a randomized controlled trial. AIDS research and treatment. 2013;2013:580974.
Uzma Q, Emmanuel F, Ather U, Zaman S. Efficacy of interventions for improving antiretroviral therapy adherence in HIV/AIDS cases at PIMS, Islamabad. J Int Assoc Physicians in AIDS Care (Chicago, Ill : 2002). 2011;10(6):373–83.
Kalichman SC, Kalichman MO, Cherry C, Swetzes C, Amaral CM, White D, et al. Brief behavioral self-regulation counseling for HIV treatment adherence delivered by cell phone: an initial test of concept trial. AIDS Patient Care STDs. 2011;25(5):303–10.
Perera AI, Thomas MG, Moore JO, Faasse K, Petrie KJ. Effect of a smartphone application incorporating personalized health-related imagery on adherence to antiretroviral therapy: a randomized clinical trial. AIDS Patient Care STDs. 2014;28(11):579–86.
Shet A, De Costa A, Kumarasamy N, Rodrigues R, Rewari BB, Ashorn P, et al. Effect of mobile telephone reminders on treatment outcome in HIV: evidence from a randomised controlled trial in India. Bmj. 2014;349:g5978.
Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838–45.
Maduka O, Tobin-West CI. Adherence counseling and reminder text messages improve uptake of antiretroviral therapy in a tertiary hospital in Nigeria. Niger J Clin Pract. 2013;16(3):302–8.
Abdulrahman SARL, Ibrahim F, Radhakrishnan AP, Kadir Shahar H, Othman N. Mobile phone reminders and peer counseling improve adherence and treatment outcomes of patients on ART in Malaysia: a randomized clinical trial. PLoS One. 2017;12(5):e0177698 https://doiorg/101371/journal pone0177698.
Ajzen I. The theory of planned behaviour: reactions and reflections. Psychology, health & medicine. 2011;26(9):1113–27.
Cochrane Handbook Cochrane Handbook for Systematic Reviews of Interventions. 2011.
Simoni JM1 KA, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.
Liu XLJ, Zhang H, Lu W, Zhang S, Zheng G, et al. Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trial. PLoS Med. 2015;12(9):e1001876. https://doi.org/101371/journalpmed1001876.
Mbuagbaw L, van der Kop ML, Lester RT, Thirumurthy H, Pop-Eleches C, Ye C, et al. Mobile phone text messages for improving adherence to antiretroviral therapy (ART): an individual patient data meta-analysis of randomised trials. BMJ Open. 2013;3(12):e003950.
Smith C UV, Ly S, Ngo T, Gold J, Free C. Mobile Technology for Improved Family Planning (MOTIF): a randomized controlled trial of a mobile phone-based (mHealth) intervention to support post-abortion family planning in Cambodia. World Health Organisation. 2015(93):834–41.
Wald DS, JPB LR, Brendell R, Wald NJ. Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial). PLoS One. 2014;9(12):e114268. https://doi.org/101371/journalpone0114268.
Gentry S1 v-VM, Tudor Car L, Car J. Telephone delivered interventions for reducing morbidity and mortality in people with HIV infection. In: Cochrane database Syst rev; 2013.
Michie SFC, West R. Development and application of a reliable system for coding the content of text messages for smoking cessation. J Smok Cessat. 2012;7(1):55–60.
Timmreck TCRJ. Smoking cessation: clinical steps to improve compliance. Geriatrics. 1993;48:63–6.
Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1993;21:1074–90.
Haessler S. The Hawthorne effect in measurements of hand hygiene compliance:a definite problem, but also an oppertunity. BMJ Qual Saf. 2014;23(12).
Claborn KR, Meier E, Miller MB, Leffingwell TR. A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy. Psychology, health & medicine. 2015;20(3):255–65.
WHO. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection 2012 [cited 2019]. Available from: https://extranet.who.int/rhl/fr/node/75722.
I would like to thank Dr. Caroline Free for her continued support with this work.
No funding was received for this work which was conducted as part of RS MSc summer project supervised by CF.
Availability of data and materials
All data used in this systematic review is contained within the published article and its additional files.
Ethics approval and consent to participate
Formal Ethics Approval is not required for a systematic review.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
PRISMA flow diagram of study selection (DOCX 42 kb)
Search strategy for EMBASE (DOCX 15 kb)
Abraham and Michie taxonomy of behaviour change technique (DOCX 108 kb)
Summary of adherence measures used by each trial (DOCX 14 kb)
Risk of bias comments (DOCX 41 kb)
Funnel plot to show publication bias of the use of mobile phone interventions delivered by text message (DOCX 23 kb)
Reasons for exclusion from the review (DOCX 21 kb)
About this article
Cite this article
Shah, R., Watson, J. & Free, C. A systematic review and meta-analysis in the effectiveness of mobile phone interventions used to improve adherence to antiretroviral therapy in HIV infection. BMC Public Health 19, 915 (2019). https://doi.org/10.1186/s12889-019-6899-6
- Medication adherence
- Mobile phone
- Health behaviour